ResMed (MEX:RMD) Inventories, Work In Process: MXN36 Mil (As of Mar. 2026)


MEX:RMD ResMed Inc MEX:RMD
99 GF Score
Price MXN3,716.10
GF Value MXN5,059.75
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ResMed Inventories, Work In Process?

ResMed MEX:RMD 99 Inventories, Work In Process is MXN36 Mil as of Mar. 2026. GuruFocus rates MEX:RMD with a GF Score™ of 99/100 and a GF Value™ of MXN5,059.75 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. ResMed's work in process for the quarter that ended in Mar. 2026 was MXN36 Mil.

ResMed Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for ResMed's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ResMed Inventories, Work In Process Chart

ResMed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.50 61.90 67.82 49.70 48.01

ResMed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.06 48.01 36.05 17.43 35.87
MEX:RMD
99GF Score
ResMed Inc MEX:RMD
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ResMed Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of MXN36 Mil mean?
ResMed (MEX:RMD) has a Inventories, Work In Process of MXN36 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on ResMed and its competitors.
Is ResMed's Inventories, Work In Process too high?
ResMed's current Inventories, Work In Process is MXN36 Mil. Overall, ResMed has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ResMed's Inventories, Work In Process compare to MDLN and WST?
ResMed's Inventories, Work In Process of MXN36 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on ResMed and its competitors. ResMed's current Inventories, Work In Process is MXN36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ResMed stock overvalued right now?
Based on GuruFocus' analysis, ResMed (MEX:RMD) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN5,059.75, compared to a current price of MXN3,716.10 — trading 26.6% below its estimated fair value. The current Inventories, Work In Process is MXN36 Mil. ResMed's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For ResMed (MEX:RMD), the current Inventories, Work In Process is MXN36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ResMed (MEX:RMD) Overvalued in 2026?

Based on GuruFocus' analysis, ResMed stock appears to be undervalued. The current stock price of MXN3,716.10 is trading 26.6% below its estimated GF Value™ of MXN5,059.75. GuruFocus considers ResMed to be Modestly Undervalued.

Key valuation signals for MEX:RMD:

  • Inventories, Work In Process: MXN36 Mil
  • GF Value™: MXN5,059.75 vs. price of MXN3,716.10 (26.6% below fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the MEX:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ResMed Business Description

Address 9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
99GF Score

Get the complete analysis for MEX:RMD

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,716.10
Price
MXN5,059.75
GF Value